Leading drug maker GSK posted a revenue of N7.8billion a 12.7% (2013 FY: N6.9billion). Gross profit also increased 8.8% to N2.9billion compared to N2.7billion. Pre-tax was N892million compared to N865million a 3.2% rise.

Screenshot (235)

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.